Aspergillus terreus

Last updated

Aspergillus terreus
Aspergillus terreus.jpg
Scientific classification OOjs UI icon edit-ltr.svg
Domain: Eukaryota
Kingdom: Fungi
Division: Ascomycota
Class: Eurotiomycetes
Order: Eurotiales
Family: Aspergillaceae
Genus: Aspergillus
Species:
A. terreus
Binomial name
Aspergillus terreus
Thom (1918) [1]

Aspergillus terreus, also known as Aspergillus terrestris, is a fungus (mold) found worldwide in soil. Although thought to be strictly asexual until recently, A. terreus is now known to be capable of sexual reproduction. [2] This saprotrophic fungus is prevalent in warmer climates such as tropical and subtropical regions. [3] Aside from being located in soil, A. terreus has also been found in habitats such as decomposing vegetation and dust. [4] A. terreus is commonly used in industry to produce important organic acids, such as itaconic acid and cis-aconitic acid, as well as enzymes, like xylanase. [3] It was also the initial source for the drug mevinolin (lovastatin), a drug for lowering serum cholesterol.

Contents

Aspergillus terreus can cause opportunistic infection in people with deficient immune systems. It is relatively resistant to amphotericin B, a common antifungal drug. [5] Aspergillus terreus also produces aspterric acid and 6-hydroxymellein, inhibitors of pollen development in Arabidopsis thaliana . [6]

In 2023, Australian scientists discovered the ability of A. terreus to decompose polypropylene plastic completely in 140 days. [7]

Appearance

Aspergillus terreus heads.jpeg
Aspergillus terreus aleurioconidia.jpg
Aspergillus terreus conidial heads (left) and aleurioconidia (right) grown on modified Leonian's agar

Aspergillus terreus is brownish in colour and gets darker as it ages on culture media. [3] [8] On Czapek or malt extract agar (MEA) medium at 25 °C (77 °F), colonies have the conditions to grow rapidly and have smooth-like walls. In some cases, they are able to become floccose, achieving hair-like soft tufts. [9] Colonies on malt extract agar grow faster and sporulate more densely than on many other media. [8]

Aspergillus terreus has conidial heads that are compact, biseriate, and densely columnar, reaching 500 × 30–50 μm in diameter. Conidiophores of A. terreus are smooth and hyaline up to 100–250 × 4–6 μm in diameter. The conidia of A. terreus are small, about 2 μm in diameter, globose-shaped, smooth-walled, and can vary from light yellow to hyaline. [10] Unique to this species is the production of aleurioconidia, asexual spores produced directly on the hyphae that are larger than the phialoconidia (e.g. 6–7 μm in diameter). This structure might be influential in the way A. terreus presents itself clinically as it can induce elevated inflammatory responses. [4] [11] [12]

This fungus is readily distinguished from the other species of Aspergillus by its cinnamon-brown colony colouration and its production of aleurioconidia. A. terreus is a thermotolerant species since it has optimal growth in temperatures between 35–40 °C (95–104 °F), and maximum growth within 45–48 °C (113–118 °F). [13]

Ecology

Aspergillus terreus, like other species of Aspergillus, produces spores that disperse efficiently in the air over a range of distances. [14] [15] The morphology of this fungus provides an accessible way for spores to disperse globally in air current. [16] Elevation of the sporulating head atop a long stalk above the growing surface may facilitate spore dispersal through the air. [17] Normally, spores in fungi are discharged into still air, but in A. terreus, it resolves this problem with a long stalk and it allows the spores to discharge into air currents like wind. [18] In turn, A. terreus has a better chance to disperse its spores amongst a vast geography which subsequently explains for the worldwide prevalence of the fungus.

Despite A. terreus being found worldwide in warm, arable soil, it has been located in many different habitats such as compost and dust. [3] Eventually, the dispersed fungal spores come into contact with either liquid or solid material and settle onto it, but only when the conditions are right do the spores germinate. One of the conditions important to the fungus is the level of moisture present in the material. The lowest water activity (Aw) capable of supporting growth of the fungus has been reported as 0.78. [4] Tolerance of relatively low Aw conditions may explain, in part, the ubiquitous nature of this species given its ability to grow is a wide array of places. [15] The soil of potted plants is one common habitat supporting the growth of A. terreus, and colonized soils may be important reservoirs of nosocomial infection. [19] Other habitats include cotton, grains, and decomposing vegetation. [4]

Genome

The Broad Fungal Genome Initiative funded by the National Institute of Allergy and Infectious Disease carried out the sequencing A. terreus in 2006. The result was 11.05 × genome sequence coverage. A. terreus contains 30-35 Mbp and roughly 10,000 protein-coding genes. [12] [20] Identification of virulence determinants within the genome of A. terreus may facilitate the development of new approaches to the treatment of A. terreus-related diseases. In addition, because A. terreus is resistant to the common antifungal drug amphotericin B, the mechanisms underlying its resistance may be better understood by genome-level investigation. [12] [21]

The polyketide synthase gene atX produces 6-Methylsalicylic acid in A. terreus. [22] [23]

Infection

Aspergillus terreus is not as common as other Aspergillus species to cause opportunistic infections in animals and humans. However, the incidence of A. terreus infection is increasing more rapidly than any other Aspergillus and for this reason it is considered an emerging agent of infection. [24]

As an opportunistic pathogen, it is able to cause both systemic and superficial infections. [25] Inhalation of fungal spores, which travel down along the respiratory tract, cause the typical respiratory infection. Other infections could also occur, such as onychomycosis and otomycosis. [25] [26] A. terreus has the ability to cause serious effects in immunocompromised patients who lack specific immune cells. Specifically, prolonged neutropenia predisposes humans and animals to this fungal disease. [17] [24]

Aspergillus terreus has no adaptation in terms of changing its physical structure when infecting a human or animal host. The fungus continues to grow as the characteristic hyphae filaments. Other pathogenic fungi usually switch over to a different growth stage, mycelia-to-yeast conversion, to best suit their new environment. This process does not occur in A. terreus. [17]

Plants

For decades, A. terreus has been used in agriculture as a means to control pathogenic fungi from destroying crops. However, during the late 1980s, researchers described A. terreus as a fungal pathogen in plants. Crops such as wheat and ryegrass were shown to acquire disease following A. terreus infection. More recently, researchers have discovered the species can also cause foliar blight of potatoes. This was first described in India. [27] A. terreus infection can have important implications because potatoes are considered the third-most important food crop in the world. [28]

Aspergillus terreus has also been shown to disrupt the male sexual reproductive cycle in the plant model organism Arabidopsis thaliana. Its secondary metabolites, aspterric acid and 6-hydroxymellein, released from the fungus inhibit the production of pollen, the male gamete in plants. Since Arabidopsis thaliana cannot reproduce, it is sterile and cannot contribute offspring to the next generation. Ultimately, this has an effect on genetic diversity in the plant species. [6]

Animals

Aspergillus terreus can cause infection in animals, but it is contained to a few species, such as dogs and cattle. Widely, A. terreus is found to cause mycotic abortion in cattle. [9] [10] [17] In dogs, especially in the German Shepherd breed, this fungus is also responsible for sinusitis. [17] It can further affect dogs through its dissemination. It can affect other parts of the body, including organs such as the spleen and kidneys. [9] Also, the bone can be affected by A. terreus which could lead to spinal osteomyelitis. [12]

Very few animal models exhibit A. terreus infections. Some successful animal models include the mouse and rabbit where A. terreus has formed pulmonary aspergillosis. These studies are important because it provides evidence that this fungal infection can cause disease. [29]

Humans

In humans, A. terreus is less commonly encountered as a pathogen than other Aspergillus species, most notably A. fumigatus, A. flavus and A. niger . [24] [26] Although less frequently seen in clinical samples, A. terreus displays evidence of amphotericin B resistance which correlates to a high rate of dissemination and an overall poor prognosis. [24] [30]

Aspergillus terreus causes opportunistic infections mostly in immunocompromised people such as COPD patients who are taking corticosteroids, cancer patients receiving chemotherapy treatment, or HIV/AIDS patients. [17] In an immunocompetent individual, the inhalation of spores initiates an immediate release of macrophages and neutrophils. In an immunosuppressed individual, this response is less vigorous. Most of these individuals suffer from neutropenia, which makes them less capable of defending themselves. In addition, A. terreus releases toxic metabolites that attack immune cells like neutrophils which provide the suitable conditions for the fungus to thrive. [26]

Aspergillus terreus infection can lead to superficial infections in humans. These affect the outside layer of the body. It is commonly isolated from onychomycosis which is infection of human skin and nails. [9] [10] The incidence of onychomycosis as a result of A. terreus (not the common agent dermatophyte) is increasing. This happens to be the most frequently reported superficial infection in clinics and hospitals. [25] Another common superficial infection caused by A. terreus includes otomycosis (ear infection), which is mostly isolated from patients who had recent surgical operations. [4] [10]

In addition, A. terreus infection can also result in four main systemic disease outcomes: [3]

Though all four disease outcomes can impose a great health risk to humans; invasive aspergillosis tends to result in the highest mortality and morbidity rates in humans. [12] Epidemiology studies have shown the incidence of A. terreus in causing invasive aspergillosis has increased relative to other species in the genus. [31] A. terreus infection causes 100% mortality rate in people who acquire invasive aspergillosis. Compared to 20 other Aspergillus species, A. terreus infection is associated with the poorest prognosis and high mortality. In fact, invasive aspergillosis has been named as the leading cause of death in leukemia and stem cell transplantation patients. [12]

Treatment and prevention

Treatment of A. terreus is clinically challenging due to its nearly complete resistance to amphotericin B, the fallback drug for serious fungal infections. [12] [24] However, some newer drugs, such as voriconazole, posaconazole, and caspofungin, have shown promise in treating this agent. [32]

The laboratory identification of A. terreus from clinical specimens can also be difficult. Currently, no rapid immunological tests are available for this species, and its correct identification remains dependent on culture. A. terreus strains have a tendency to mutate while in the animal host, resulting in a substantial reduction or loss of characteristic spore heads in primary culture. Such strains continue to produce small aleuroconidia similar in appearance to the aleurioconidia of Blastomyces dermatitidis.

In one study, nearly a third of A. terreus infections in hospitals were found to be associated with the presence of potted plants. [24] Elimination of potted plants in the rooms of immunodeficient patients may have a role in prevention of illness. A. terreus has also been described in many studies as common to the hospital setting because of outside hospital construction and renovations. The amount of soil and debris reintroduced into the air is capable of travelling through the air and infecting immunosuppressed patients. [33] A simple way to take preventive action is to provide good air filtration and ventilation throughout the hospital rooms. Elimination of inoculum is key to the prevention of nosocomial infection by A. terreus. [34]

Industrial uses

Aspergillus terreus produces a number of secondary metabolites and mycotoxins, including territrem A, citreoviridin, citrinin, gliotoxin, patulin, terrein, terreic acid, asterric acid, and terretonin. [12] [35] The fungus also produces a secondary metabolite called lovastatin, a potent drug for lowering blood cholesterol levels in humans and animals. It is an inhibitor to one of the enzymes responsible in the catalyzing steps in cholesterol biosynthesis. Lovastatin is typically produced within fermentation conditions of the fungus. Fast growth of filamentous hyphae in the species A. terreus can result in low lovastatin production. To increase the production of this metabolite A. terreus requires important nutrients during fermentation. In this case, carbon and nitrogen are very important in fermentation productivity which in turn also increases the biomass of the metabolite lovastatin. [36] A. terreus strains use glycerol and glucose as their best carbon sources for lovastatin production. [37]

It is also used to produce the drug simvastatin that is chemically related to lovastatin. [38]

Related Research Articles

<span class="mw-page-title-main">Mold</span> Wooly, dust-like fungal structure or substance

A mold or mould is one of the structures that certain fungi can form. The dust-like, colored appearance of molds is due to the formation of spores containing fungal secondary metabolites. The spores are the dispersal units of the fungi. Not all fungi form molds. Some fungi form mushrooms; others grow as single cells and are called microfungi.

<i>Aspergillus niger</i> Species of fungus

Aspergillus niger is a mold classified within the Nigri section of the Aspergillus genus. The Aspergillus genus consists of common molds found throughout the environment within soil and water, on vegetation, in fecal matter, on decomposing matter, and suspended in the air. Species within this genus often grow quickly and can sporulate within a few days of germination. A combination of characteristics unique to A. niger makes the microbe invaluable to the production of many acids, proteins and bioactive compounds. Characteristics including extensive metabolic diversity, high production yield, secretion capability, and the ability to conduct post-translational modifications are responsible for A. niger's robust production of secondary metabolites. A. niger's capability to withstand extremely acidic conditions makes it especially important to the industrial production of citric acid.

<i>Aspergillus flavus</i> Species of fungus

Aspergillus flavus is a saprotrophic and pathogenic fungus with a cosmopolitan distribution. It is best known for its colonization of cereal grains, legumes, and tree nuts. Postharvest rot typically develops during harvest, storage, and/or transit. Its specific name flavus derives from the Latin meaning yellow, a reference to the frequently observed colour of the spores. A. flavus infections can occur while hosts are still in the field (preharvest), but often show no symptoms (dormancy) until postharvest storage or transport. In addition to causing preharvest and postharvest infections, many strains produce significant quantities of toxic compounds known as mycotoxins, which, when consumed, are toxic to mammals. A. flavus is also an opportunistic human and animal pathogen, causing aspergillosis in immunocompromised individuals.

<i>Aspergillus fumigatus</i> Species of fungus

Aspergillus fumigatus is a species of fungus in the genus Aspergillus, and is one of the most common Aspergillus species to cause disease in individuals with an immunodeficiency.

<i>Aspergillus</i> Genus of fungi

Aspergillus is a genus consisting of several hundred mould species found in various climates worldwide.

<span class="mw-page-title-main">Aspergillosis</span> Medical condition

Aspergillosis is a fungal infection of usually the lungs, caused by the genus Aspergillus, a common mould that is breathed in frequently from the air, but does not usually affect most people. It generally occurs in people with lung diseases such as asthma, cystic fibrosis or tuberculosis, or those who are immunocompromized such as those who have had a stem cell or organ transplant or those who take medications such as steroids and some cancer treatments which suppress the immune system. Rarely, it can affect skin.

<span class="mw-page-title-main">Gliotoxin</span> Chemical compound

Gliotoxin is a sulfur-containing mycotoxin that belongs to a class of naturally occurring 2,5-diketopiperazines produced by several species of fungi, especially those of marine origin. It is the most prominent member of the epipolythiopiperazines, a large class of natural products featuring a diketopiperazine with di- or polysulfide linkage. These highly bioactive compounds have been the subject of numerous studies aimed at new therapeutics. Gliotoxin was originally isolated from Gliocladium fimbriatum, and was named accordingly. It is an epipolythiodioxopiperazine metabolite that is one of the most abundantly produced metabolites in human invasive Aspergillosis (IA).

<span class="mw-page-title-main">Echinocandin</span> Group of chemical compounds

Echinocandins are a class of antifungal drugs that inhibit the synthesis of β-glucan in the fungal cell wall via noncompetitive inhibition of the enzyme 1,3-β glucan synthase. The class has been termed the "penicillin of antifungals," along with the related papulacandins, as their mechanism of action resembles that of penicillin in bacteria. β-glucans are carbohydrate polymers that are cross-linked with other fungal cell wall components, the fungal equivalent to bacterial peptidoglycan. Caspofungin, micafungin, and anidulafungin are semisynthetic echinocandin derivatives with limited clinical use due to their solubility, antifungal spectrum, and pharmacokinetic properties.

Pathogenic fungi are fungi that cause disease in humans or other organisms. Although fungi are eukaryotic, many pathogenic fungi are microorganisms. Approximately 300 fungi are known to be pathogenic to humans; their study is called "medical mycology". Fungal infections kill more people than either tuberculosis or malaria—about 2 million people per year.

<span class="mw-page-title-main">Chronic pulmonary aspergillosis</span> Fungal infection

Chronic pulmonary aspergillosis is a long-term fungal infection caused by members of the genus Aspergillus—most commonly Aspergillusfumigatus. The term describes several disease presentations with considerable overlap, ranging from an aspergilloma—a clump of Aspergillus mold in the lungs—through to a subacute, invasive form known as chronic necrotizing pulmonary aspergillosis which affects people whose immune system is weakened. Many people affected by chronic pulmonary aspergillosis have an underlying lung disease, most commonly tuberculosis, allergic bronchopulmonary aspergillosis, asthma, or lung cancer.

Aspergillus sydowii is a pathogenic fungus that causes several diseases in humans. It has been implicated in the death of sea fan corals in the Caribbean Sea.

<i>Aspergillus versicolor</i> Species of fungus

Aspergillus versicolor is a slow-growing species of filamentous fungus commonly found in damp indoor environments and on food products. It has a characteristic musty odor associated with moldy homes and is a major producer of the hepatotoxic and carcinogenic mycotoxin sterigmatocystin. Like other Aspergillus species, A. versicolor is an eye, nose, and throat irritant.

<i>Aspergillus ustus</i> Species of fungus

Aspergillus ustus is a microfungus and member of the division Ascomycota. It is commonly found in indoor environments and soil. Isolated cases of human infection resulting from A. ustus have been described; however the majority of these are nail infections.

<i>Aspergillus candidus</i> Species of fungus

Aspergillus candidus is a white-spored species of fungus in the genus Aspergillus. Despite its lack of pigmentation, it is closely related to the most darkly-pigmented aspergilli in the Aspergillus niger group. It is a common soil fungus worldwide and is known as a contaminant of a wide array of materials from the indoor environment to foods and products. It is an uncommon agent of onychomycosis and aspergillosis. The species epithet candidus (L.) refers to the white pigmentation of colonies of this fungus. It is from the Candidi section. The fungi in the Candidi section are known for their white spores. It has been isolated from wheat flour, djambee, and wheat grain.

Medicinal fungi are fungi that contain metabolites or can be induced to produce metabolites through biotechnology to develop prescription drugs. Compounds successfully developed into drugs or under research include antibiotics, anti-cancer drugs, cholesterol and ergosterol synthesis inhibitors, psychotropic drugs, immunosuppressants and fungicides.

<span class="mw-page-title-main">Human interactions with fungi</span> Overview of human—fungi interactions

Human interactions with fungi include both beneficial uses, whether practical or symbolic, and harmful interactions such as when fungi damage crops, timber, food, or are pathogenic to animals.

<i>Aspergillus clavatus</i> Species of fungus

Aspergillus clavatus is a species of fungus in the genus Aspergillus with conidia dimensions 3–4.5 x 2.5–4.5 μm. It is found in soil and animal manure. The fungus was first described scientifically in 1834 by the French mycologist John Baptiste Henri Joseph Desmazières.

<i>Aspergillus alabamensis</i> Species of fungus

Aspergillus alabamensis is a soil fungus in the division Ascomycota first described in 2009 as a segregated taxon of A. terreus. Originally thought to be a variant of A. terreus, A. alabamensis is situated in a distinctive clade identified by genetic analysis. While A. alabamensis has been found to be morphologically similar to Aspergillus terreus by morphological studies, the two differ significantly in active metabolic pathways, with A. alabamensis producing the mycotoxins citrinin and citreoviridin but lacking mevinolin.

Aspergillus wentii is an asexual, filamentous, endosymbiotic fungus belonging to the mold genus, Aspergillus. It is a common soil fungus with a cosmopolitan distribution, although it is primarily found in subtropical regions. Found on a variety of organic materials, A. wentii is known to colonize corn, cereals, moist grains, peanuts and other ground nut crops. It is also used in the manufacture of biodiesel from lipids and is known for its ability to produce enzymes used in the food industry.

Microascus manginii is a filamentous fungal species in the genus Microascus. It produces both sexual (teleomorph) and asexual (anamorph) reproductive stages known as M. manginii and Scopulariopsis candida, respectively. Several synonyms appear in the literature because of taxonomic revisions and re-isolation of the species by different researchers. M. manginii is saprotrophic and commonly inhabits soil, indoor environments and decaying plant material. It is distinguishable from closely related species by its light colored and heart-shaped ascospores used for sexual reproduction. Scopulariopsis candida has been identified as the cause of some invasive infections, often in immunocompromised hosts, but is not considered a common human pathogen. There is concern about amphotericin B resistance in S. candida.

References

  1. ↑ Thom C, Church M.B. (1918). "Aspergillus fumigatus, A. nidulans, A. terreus n. sp. and their allies". American Journal of Botany. 5 (2): 84–104. doi:10.2307/2435130. JSTOR   2435130.
  2. ↑ Arabatzis M, Velegraki A (2013). "Sexual reproduction in the opportunistic human pathogen Aspergillus terreus". Mycologia. 105 (1): 71–9. doi:10.3852/11-426. PMID   23074177. S2CID   9584227.
  3. 1 2 3 4 5 "Fungal Infections Aspergillus terreus". Leading International Fungal Education. Archived from the original on 2 December 2013. Retrieved 13 October 2013.
  4. 1 2 3 4 5 "Aspergillus terreus". University of Minnesota. Archived from the original on 23 September 2015. Retrieved 13 October 2013.
  5. ↑ "Aspergillus terreus". Doctor of Fungus. Archived from the original on 3 December 2013. Retrieved 14 October 2013.
  6. 1 2 Shimada, A; Kusano,M; Takeuchi,S; Fujioka,S; Inokuchi,T; Kimura, Y (2002). "Aspterric acid and 6-hydroxymellein, inhibitors of pollen development in Arabidopsis thaliana, produced by Aspergillus terreus". Journal of Biosciences. 57 (5–6): 459–464. doi: 10.1515/znc-2002-5-610 . PMID   12132685. S2CID   37714214.
  7. ↑ Tran, Danny (14 April 2023). "Plastic-eating backyard fungi discovery boosts hopes for a solution to the recycling crisis". Australian Broadcasting Corporation News . Retrieved 26 April 2023.
  8. 1 2 Samson, R.A.; Hoekstra, E.S.; Frisvad, J.C. (2004). Introduction to food- and airborne fungi.
  9. 1 2 3 4 "ASPERGILLUS TERREUS" (PDF). IMI Descriptions of Fungi and Bacteria No. 1253. Retrieved 14 October 2013.
  10. 1 2 3 4 "ASPERGILLUS TERREUS" (PDF). C.M.I. Descriptions of Pathogenic Fungi and Bacteria No. 95. Retrieved 13 October 2013.
  11. ↑ Lass-Florl, Cornelia (2012). "Aspergillus terreus: How Inoculum Size and Host Characteristics Affect Its Virulence". The Journal of Infectious Diseases. 205 (8): 1192–1194. doi: 10.1093/infdis/jis185 . PMID   22438395.
  12. 1 2 3 4 5 6 7 8 "Comparative analysis of an emerging fungal pathogen, Aspergillus terreus" (PDF). 2006. Archived from the original (PDF) on 2006-08-15.
  13. ↑ Anderson, K.H. Domsch ; W. Gams ; Traute-Heidi (1980). Compendium of soil fungi (2nd print. ed.). London, UK: Academic Press. ISBN   9780122204029.{{cite book}}: CS1 maint: multiple names: authors list (link)
  14. ↑ Hedayati, M.T.; Pasqualotto, Warn; Bowyer, Denning (2007). "Aspergillus flavus: human pathogen, allergen and mycotoxin producer". Journal of Medical Microbiology. 153 (6): 1677–1692. doi: 10.1099/mic.0.2007/007641-0 . PMID   17526826 . Retrieved 9 November 2013.
  15. 1 2 "Aspergillus" . Retrieved 9 November 2013.
  16. ↑ "FUNGI REPRODUCING ASEXUALLY BY MEANS OF CONIDIA". New Brunswick Museum. Archived from the original on 13 November 2013. Retrieved 10 November 2013.
  17. 1 2 3 4 5 6 Summerbell, Richard. "Lecture 9 – Opportunistic mycoses I:  Aspergillosis, Sporotrichosis, Zygomycosis &  Rhinosporidiosis" (PDF). Archived from the original (PDF) on 2013-12-02.
  18. ↑ Fogel, Robert. "Spore dispersal: The big gamble". Archived from the original on 18 January 2004. Retrieved 10 November 2013.
  19. ↑ Hedayati, M.T.; Mohseni-Bandpi, Moradi (2004). "A survey on the pathogenic fungi in soil samples of potted plants from Sari hospitals, Iran". Journal of Hospital Infection. 58 (1): 59–62. doi:10.1016/j.jhin.2004.04.011. PMID   15350715.
  20. ↑ "Genomes". CADRE. Archived from the original on 27 July 2012. Retrieved 15 October 2013.
  21. ↑ "Descriptions". BROAD Institute. Retrieved 15 October 2013.
  22. ↑ Anyaogu, Diana Chinyere; Mortensen, Uffe Hasbro (2015-02-10). "Heterologous production of fungal secondary metabolites in Aspergilli". Frontiers in Microbiology . Frontiers. 6: 77. doi: 10.3389/fmicb.2015.00077 . ISSN   1664-302X. PMC   4322707 . PMID   25713568.
  23. ↑ Atanasov, Atanas G.; Zotchev, Sergey B.; Dirsch, Verena M.; Supuran, Claudiu T.; et al. (The International Natural Product Sciences Taskforce) (2021-01-28). "Natural products in drug discovery: advances and opportunities". Nature Reviews Drug Discovery . Nature Portfolio. 20 (3): 200–216. doi:10.1038/s41573-020-00114-z. ISSN   1474-1776. PMC   7841765 . PMID   33510482.
  24. 1 2 3 4 5 6 Lass-Florl, Cornelia; Griff K.; Mayr A.; Petzer A.; Gastl G.; Bonatti H.; Freund M.; Kropshofer G.; Dierich M.; Nachbaur D. (2005). "Epidemiology and outcome of infections due to Aspergillus terreus: 10-year single centre experience". British Journal of Haematology. 131 (2): 20–207. doi: 10.1111/j.1365-2141.2005.05763.x . PMID   16197450. S2CID   28216328.
  25. 1 2 3 Fernandez, Mariana; Rojas F.; Cattana M.; Sosa M.; Mangiaterra M.; Giusiano G. (2013). "Aspergillus terreus complex: an emergent opportunistic agent of Onychomycosis". Mycoses. 56 (4): 477–481. doi:10.1111/myc.12061. hdl: 11336/9305 . PMID   23448599. S2CID   35391600.
  26. 1 2 3 "Aspergillosis" . Retrieved 10 November 2013.
  27. ↑ Louis, B; Roy P.; Sayanika D.; Talukdar N (2013). "Aspergillus terreus Thom a new pathogen that causes foliar blight of potato" (PDF). Plant Pathology & Quarantine. 3: 29–33. doi: 10.5943/ppq/3/1/5 .
  28. ↑ Molina, La. "Facts & figures". International Potato Center. Retrieved 12 November 2013.
  29. ↑ Lass-Florl, Cornelia (20 March 2012). "Aspergillus terreus: How Inoculum Size and Host Characteristics Affect Its Virulence". Journal of Infectious Diseases. 205 (8): 1192–1194. doi: 10.1093/infdis/jis185 . PMID   22438395.
  30. ↑ Slesiona, S.; Ibrahim-Granet, O.; Olias, P.; Brock, M.; Jacobsen, I. D. (20 March 2012). "Murine Infection Models for Aspergillus terreus Pulmonary Aspergillosis Reveal Long-term Persistence of Conidia and Liver Degeneration". Journal of Infectious Diseases. 205 (8): 1268–1277. doi: 10.1093/infdis/jis193 . PMID   22438397.
  31. ↑ Baddley, J. W.; Pappas, P. G.; Smith, A. C.; Moser, S. A. (8 December 2003). "Epidemiology of Aspergillus terreus at a University Hospital". Journal of Clinical Microbiology. 41 (12): 5525–5529. doi:10.1128/JCM.41.12.5525-5529.2003. PMC   308992 . PMID   14662934.
  32. ↑ Goldberg, S. L.; Geha, D. J.; Marshall, W. F.; Inwards, D. J.; Hoagland, H. C. (1 June 1993). "Successful Treatment of Simultaneous Pulmonary Pseudallescheria boydii and Aspergillus terreus Infection with Oral Itraconazole". Clinical Infectious Diseases. 16 (6): 803–805. doi:10.1093/clind/16.6.803. PMID   8392389.
  33. ↑ Flynn, Patricia; Williams B.; Hetherington S.; Williams B.; Giannini M.; Pearson T. (1993). "Aspergillus terreus During Hospital Renovation". Infection Control and Hospital Epidemiology. 14 (7): 363–365. doi:10.1086/646761. JSTOR   30148315. PMID   8354865.
  34. ↑ Hoog, G.S. "Pathogenicity". Mycobank. Retrieved 4 November 2013.
  35. ↑ Yang, Xiao-Long; Zhang, Jing-Ze; Luo, Du-Qiang (2012-06-01). "The taxonomy, biology and chemistry of the fungal Pestalotiopsis genus". Natural Product Reports. 29 (6): 622–641. doi:10.1039/C2NP00073C. ISSN   1460-4752.
  36. ↑ Lopez, J.L; Perez J.L.; Sevilla J.M.; Fernandez FG.; Grima E.; Chisti Y (2003). "Production of lovastatin by Aspergillus terreus: effects of the C:N ratio and the principal nutrients on growth and metabolite production" (PDF). Enzyme and Microbial Technology. 33 (2–3): 270–277. CiteSeerX   10.1.1.562.5554 . doi:10.1016/s0141-0229(03)00130-3. Archived from the original (PDF) on 2018-02-20. Retrieved 2013-11-24.
  37. ↑ Szakacs, G; Morovjan G.; Tengerdy R (1998). "Production of lovastatin by a wild strain of Aspergillus terreus". Biotechnology Letters. 20 (4): 411–415. doi:10.1023/A:1005391716830. S2CID   20240260.
  38. ↑ Cechinel-Filho, Valdir (2012). Plant bioactives and drug discovery: principles, practice, and perspectives. Hoboken, N.J.: John Wiley & Sons. p. 104. ISBN   9780470582268. Archived from the original on 2016-03-05.
This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.